CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
176
176
156
168
237
222
Revenue Growth (YoY)
-23%
13%
-7%
-28.99%
7%
185%
Cost of Revenue
93
93
87
93
133
126
Gross Profit
83
83
69
75
103
96
Selling, General & Admin
102
102
109
108
120
97
Research & Development
17
17
17
18
15
16
Operating Expenses
119
119
127
126
135
114
Other Non Operating Income (Expenses)
-2
-2
-7
5
-5
-2
Pretax Income
-32
-32
-104
-84
-35
-273
Income Tax Expense
1
1
0
0
2
1
Net Income
66
70
-122
-107
-45
-283
Net Income Growth
-154%
-157%
14%
138%
-84%
277%
Shares Outstanding (Diluted)
49.95
50.07
49.34
48.73
49
45.9
Shares Change (YoY)
1%
1%
1%
-1%
7%
19%
EPS (Diluted)
1.33
1.4
-2.48
-2.2
-0.93
-6.18
EPS Growth
-153%
-156%
13%
137%
-85%
219%
Free Cash Flow
-28
-28
-37
-45
-26
-16
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
47.15%
47.15%
44.23%
44.64%
43.45%
43.24%
Operating Margin
-20.45%
-20.45%
-36.53%
-29.76%
-13.08%
-7.65%
Profit Margin
37.5%
39.77%
-78.2%
-63.69%
-18.98%
-127.47%
Free Cash Flow Margin
-15.9%
-15.9%
-23.71%
-26.78%
-10.97%
-7.2%
EBITDA
-9
-9
-27
-23
-9
3
EBITDA Margin
-5.11%
-5.11%
-17.3%
-13.69%
-3.79%
1.35%
D&A For EBITDA
27
27
30
27
22
20
EBIT
-36
-36
-57
-50
-31
-17
EBIT Margin
-20.45%
-20.45%
-36.53%
-29.76%
-13.08%
-7.65%
Effective Tax Rate
-3.12%
-3.12%
0%
0%
-5.71%
-0.36%
Follow-Up Questions
What are Cryoport Inc's key financial statements?
According to the latest financial statement (Form-10K), Cryoport Inc has a total asset of $764, Net profit of $70
What are the key financial ratios for CYRX?
Cryoport Inc's Current ratio is 2.91, has a Net margin is 39.77, sales per share of $3.51.
How is Cryoport Inc's revenue broken down by segment or geography?
Cryoport Inc largest revenue segment is Life Sciences Services, at a revenue of 156,951,000 in the most earnings release.For geography, Americas is the primary market for Cryoport Inc, at a revenue of 126,373,000.
Is Cryoport Inc profitable?
yes, according to the latest financial statements, Cryoport Inc has a net profit of $70
Does Cryoport Inc have any liabilities?
yes, Cryoport Inc has liability of 262
How many outstanding shares for Cryoport Inc?
Cryoport Inc has a total outstanding shares of 49.85